TABLE 3

The relationship between GDP concentration and agonist potency

In the experiments at 0.1 nM [35S]GTPγS, all compounds had similar slopes (P > 0.05), with the exception of bromocriptine. In the experiments at 10 nM [35S]GTPγS, the slope for 7-OH-DPAT was different from 0 (P < 0.05) and was different from slopes for other compounds (P < 0.05); the slope for p-tyramine was not different from 0 (P > 0.05), and the slopes for dopamine and NPA were different from those for (±)-7-OH-DPAT and p-tyramine. Slopes for NPA or dopamine were different at the two concentrations of [35S]GTPγS. The slopes of the lines shown in Fig. 5 were determined by linear regression.

Slope
0.1 nM [35S[GTPγS 10 nM [35S]GTPγS
Dopamine −0.31 ± 0.06 −0.47 ± 0.04
Bromocriptine 0.02 ± 0.04 N.D.
(±)-7-OH-DPAT −0.31 ± 0.04 −0.20 ± 0.07
NPA −0.37 ± 0.06 −0.55 ± 0.03
Quinpirole −0.29 ± 0.05 N.D.
β-Phenylethylamine −0.24 ± 0.05 N.D.
p-Tyramine −0.32 ± 0.03 −0.04 ± 0.09
m-Tyramine −0.30 ± 0.04 N.D.
  • N.D., not determined.